Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies

Nitisinone (NTBC) was recently approved to treat alkaptonuria (AKU), but there is no information on its impact on oxidative stress and inflammation, which are observed in AKU. Therefore, serum samples collected during the clinical studies SONIA1 (40 AKU patients) and SONIA2 (138 AKU patients) were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Braconi, Daniela, Geminiani, Michela, Psarelli, Eftychia Eirini, Giustarini, Daniela, Marzocchi, Barbara, Rossi, Ranieri, Bernardini, Giulia, Spiga, Ottavia, Gallagher, James A., Le Quan Sang, Kim-Hanh, Arnoux, Jean-Baptiste, Imrich, Richard, Al-Sbou, Mohammed S., Gornall, Matthew, Jackson, Richard, Ranganath, Lakshminarayan R., Santucci, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688277/
https://www.ncbi.nlm.nih.gov/pubmed/36429096
http://dx.doi.org/10.3390/cells11223668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688277/
https://www.ncbi.nlm.nih.gov/pubmed/36429096
http://dx.doi.org/10.3390/cells11223668

Ejemplares similares